Lenz HJ - Search Results

1

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Gerger A, El-Khoueiry A, Zhang W, Yang D, Singh H, Bohanes P, Ning Y, Winder T, Labonte MJ, Wilson PM, Benhaim L, Paez D, El-Khoueiry R, Absenger G, Lenz HJ. Gerger A, et al. Among authors: lenz hj. Clin Cancer Res. 2011 Sep 1;17(17):5783-92. doi: 10.1158/1078-0432.CCR-11-1115. Epub 2011 Jul 26. Clin Cancer Res. 2011. PMID: 21791631 Free PMC article.

2

The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma.

Stoehlmacher J, Ingles SA, Park DJ, Zhang W, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. Oncol Rep. 2002 Mar-Apr;9(2):235-8. Oncol Rep. 2002. PMID: 11836586

3

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer.

Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei D, Groshen S, Lenz HJ. Park DJ, et al. Among authors: lenz hj. Int J Colorectal Dis. 2002 Jan;17(1):46-9. doi: 10.1007/s003840100358. Int J Colorectal Dis. 2002. PMID: 12018454

4

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. J Natl Cancer Inst. 2002 Jun 19;94(12):936-42. doi: 10.1093/jnci/94.12.936. J Natl Cancer Inst. 2002. PMID: 12072547

5

Targeted therapy and pharmacogenomic programs.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Cancer. 2003 Apr 15;97(8 Suppl):2076-82. doi: 10.1002/cncr.11287. Cancer. 2003. PMID: 12673699 Free article. Review.

6

Implications of genetic testing in the management of colorectal cancer.

Stoehlmacher J, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. Am J Pharmacogenomics. 2003;3(2):73-88. doi: 10.2165/00129785-200303020-00001. Am J Pharmacogenomics. 2003. PMID: 12749725 Review.

7

Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.

Ramanathan RK, Clark JW, Kemeny NE, Lenz HJ, Gococo KO, Haller DG, Mitchell EP, Kardinal CG. Ramanathan RK, et al. Among authors: lenz hj. J Clin Oncol. 2003 Aug 1;21(15):2904-11. doi: 10.1200/JCO.2003.11.045. J Clin Oncol. 2003. PMID: 12885808

8

Molecular predictors of treatment and outcome in colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Curr Gastroenterol Rep. 2003 Oct;5(5):399-405. doi: 10.1007/s11894-003-0053-3. Curr Gastroenterol Rep. 2003. PMID: 12959721 Review.

9

Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study.

Lara PN Jr, Frankel P, Mack PC, Gumerlock PH, Galvin I, Martel CL, Longmate J, Doroshow JH, Lenz HJ, Lau DH, Gandara DR. Lara PN Jr, et al. Among authors: lenz hj. Clin Cancer Res. 2003 Oct 1;9(12):4356-62. Clin Cancer Res. 2003. PMID: 14555506 Clinical Trial.

10

SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.

Lara PN Jr, Quinn DI, Margolin K, Meyers FJ, Longmate J, Frankel P, Mack PC, Turrell C, Valk P, Rao J, Buckley P, Wun T, Gosselin R, Galvin I, Gumerlock PH, Lenz HJ, Doroshow JH, Gandara DR; California Cancer Consortium. Lara PN Jr, et al. Among authors: lenz hj. Clin Cancer Res. 2003 Oct 15;9(13):4772-81. Clin Cancer Res. 2003. PMID: 14581348 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

683 results

Search Page